Home |
Free Dividend Report |
Stock Splits Calendar |
FGEN Historical Stock Prices |
Preferred Stock Newsletter |
FGEN Options Chain |
Stock Message Boards |
FibroGen (FGEN) has the following price history information. Looking back at FGEN historical stock prices for the last five trading days, on April 19, 2024, FGEN opened at $1.16, traded as high as $1.18 and as low as $1.05, and closed at $1.15. Trading volume was a total of 1.31M shares. On April 22, 2024, FGEN opened at $1.15, traded as high as $1.17 and as low as $1.08, and closed at $1.14. Trading volume was a total of 803.90K shares. On April 23, 2024, FGEN opened at $1.15, traded as high as $1.26 and as low as $1.05, and closed at $1.07. Trading volume was a total of 1.35M shares. On April 24, 2024, FGEN opened at $1.06, traded as high as $1.10 and as low as $0.93, and closed at $0.98. Trading volume was a total of 2.17M shares. On April 25, 2024, FGEN opened at $0.95, traded as high as $1.02 and as low as $0.90, and closed at $1.02. Trading volume was a total of 1.26M shares.
FGEN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into FibroGen shares, starting with a $10,000 purchase of FGEN, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 11/17/2014 | |
End date: | 04/25/2024 | |
Start price/share: | $23.81 | |
End price/share: | $1.02 | |
Dividends collected/share: | $0.00 | |
Total return: | -95.72% | |
Average Annual Total Return: | -28.37% | |
Starting investment: | $10,000.00 | |
Ending investment: | $428.49 | |
Years: | 9.44 |
FGEN Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/19/2024 | $1.16 | $1.18 | $1.05 | $1.15 | 1.31M |
04/22/2024 | $1.15 | $1.17 | $1.08 | $1.14 | 803.90K |
04/23/2024 | $1.15 | $1.26 | $1.05 | $1.07 | 1.35M |
04/24/2024 | $1.06 | $1.10 | $0.93 | $0.98 | 2.17M |
04/25/2024 | $0.95 | $1.02 | $0.90 | $1.02 | 1.26M |
About FibroGen |
FibroGen is a biopharmaceutical company that developes and commercializes a pipeline of therapeutics. Co. applies its capability in hypoxia-inducible factor (HIF) biology and connective tissue growth factor (CTGF) biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, Co.'s main product, is an inhibitor of HIF-prolyl hydroxylase activity that acts by stimulating the body's natural pathway of erythropoiesis or red blood cell production. Pamrevlumab is Co.'s human monoclonal antibody that inhibits the activity of CTGF for the treatment of idiopathic pulmonary fibrosis, locally advanced unresectable pancreatic cancer, and Duchenne muscular dystroph. |
FGEN Historical Closing Prices | |
Date | Close |
04/19/2024 | $1.15 |
04/22/2024 | $1.14 |
04/23/2024 | $1.07 |
04/24/2024 | $0.98 |
04/25/2024 | $1.02 |
Healthcare Historical Prices |
FGEN is categorized under the Healthcare sector; below are some other companies in the same sector:
FLDM Historical Stock Prices Also explore: FGEN shares outstanding history
Free FGEN Email Alerts:
|
FGEN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.